Alkermes Posts Q3 2026 Results, Call Set for 8:00 a.m. ET
ALKS sits 69% above its 52-week low of $27.
Summary
Alkermes released third-quarter 2026 results for the period ended September 30, with revenue beating expectations on LUMRYZ growth. The press release carries no revenue, EPS, or guidance figures — the numbers sit in the linked release and presentation on the investor site. The quarter is the first full comparison point after Q2 revenue jumped 27% to $496 million with LUMRYZ added, while acquisition-related costs held net income to $0.5 million and full-year GAAP guidance was widened. Management discusses the results and gives a business update on the 8:00 a.m. ET call today, so the substance lands there rather than in this headline.
At the time of this announcement, ALKS was trading at $45.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.5B. The 52-week trading range was $27.00 to $55.67. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.